Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Extensive irregular Mongolian blue spots as a clue for GM1 gangliosidosis type 1.

Bersani G, Guerriero C, Ricci F, Valentini P, Zampino G, Lazzareschi I, Antuzzi D, Rigante D.

J Dtsch Dermatol Ges. 2016 Jan 14. doi: 10.1111/ddg.12755. [Epub ahead of print] No abstract available.

PMID:
26765271
2.

Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment: preliminary results.

Bersani G, Quartini A, Zullo D, Iannitelli A.

Hum Psychopharmacol. 2016 Jan;31(1):19-28. doi: 10.1002/hup.2510. Epub 2015 Nov 13.

PMID:
26563456
3.

[A survey on the use of patent expired drugs in psychiatric disorders: the psychiatrists' and neurologists' opinion and competence].

Bersani G.

Riv Psichiatr. 2015 Sep-Oct;50(5):228-38. doi: 10.1708/2040.22164. Italian.

PMID:
26489072
4.

[Legalization of cannabis: between political irresponsibility and loss of responsibility of psychiatrists].

Bersani G, Iannitelli A.

Riv Psichiatr. 2015 Sep-Oct;50(5):195-8. doi: 10.1708/2040.22156. Italian.

PMID:
26489068
5.

Prognostic factors on survival rate of fingers replantation.

Lima JQ Jr, Carli AD, Nakamoto HA, Bersani G, Crepaldi BE, de Rezende MR.

Acta Ortop Bras. 2015 Jan-Feb;23(1):16-8. doi: 10.1590/1413-78522015230101026.

6.

Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.

Valeriani G, Corazza O, Bersani FS, Melcore C, Metastasio A, Bersani G, Schifano F.

Hum Psychopharmacol. 2015 Jul;30(4):249-54. doi: 10.1002/hup.2431.

PMID:
26216558
7.

The "Eyeballing" technique: an emerging and alerting trend of alcohol misuse.

Bersani FS, Corazza O, Albano G, Bruschi S, Minichino A, Vicinanza R, Bersani G, Martinotti G, Schifano F.

Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2311-7.

8.

Generalized and specific emotion impairments as potential markers of severity in Obsessive-Compulsive Disorder: a preliminary study using Facial Action Coding System (FACS).

Valeriani G, Bersani FS, Liberati D, Polli E, Girolami MT, Zullo D, Imperatori C, Melcore C, Tomassini L, Albano G, Posocco FB, Bersani G.

Psychiatr Danub. 2015 Jun;27(2):159-67.

9.

Phytonadione Content in Branded Intravenous Fat Emulsions: A Comparative Study of 6 Products With Different Fat Sources Using Liquid Chromatography-Mass Spectrometry.

Forchielli ML, Conti M, Motta R, Puggioli C, Bersani G.

JPEN J Parenter Enteral Nutr. 2015 Jun 3. pii: 0148607115589989. [Epub ahead of print]

PMID:
26041821
10.
11.

[A case of shared psychotic disorder (folie à deux) with original aspects associated with cross-cultural elements].

Cuoco V, Colletti C, Anastasia A, Weisz F, Bersani G.

Riv Psichiatr. 2015 Jan-Feb;50(1):43-6. doi: 10.1708/1794.19538. Italian.

PMID:
25805355
12.

[Omosexual parents: does a need exist for a reflection by mental health experts?].

Bersani G, Iannitelli A.

Riv Psichiatr. 2015 Jan-Feb;50(1):1-2. doi: 10.1708/1794.19522. Italian.

PMID:
25805347
13.

PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists.

Cantarini L, Vitale A, Bersani G, Nieves LM, Cattalini M, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Galeazzi M, Ceribelli A, Brunetta E, Selmi C, Rigante D.

Clin Rheumatol. 2015 Feb 10. [Epub ahead of print]

PMID:
25665824
14.

Dissociative symptoms in female patients with mood and anxiety disorders: a psychopathological and temperamental investigation.

Bersani G, Moscariello MA, Bersani FS, Colletti C, Anastasia A, Prinzivalli E, Valeriani G, Salviati M.

Eur Rev Med Pharmacol Sci. 2014;18(21):3217-22.

15.

Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study.

Rapinesi C, Curto M, Kotzalidis GD, Del Casale A, Serata D, Ferri VR, Di Pietro S, Scatena P, Bersani FS, Raccah RN, Digiacomantonio V, Ferracuti S, Bersani G, Zangen A, Angeletti G, Girardi P.

J Affect Disord. 2015 Mar 15;174:57-63. doi: 10.1016/j.jad.2014.11.015. Epub 2014 Nov 20.

PMID:
25484178
16.

[Socio-demographic, clinical and criminological features of a population discharged from forensic hospital and admitted to neuropsychiatric clinic, in scheme of restriction of freedom].

Anastasia A, Cataldo D, Colletti C, Di Falco R, Centracchio I, Del Nero P, Rinaldi R, Bersani G.

Riv Psichiatr. 2014 Sep-Oct;49(5):235-42. doi: 10.1708/1668.18266. Italian.

PMID:
25424336
17.

Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): keynote addresses and conference abstracts.

Parrott AC, Corazza O, Schifano F, Griffiths P, Sedefov R, Gallegos A, Murray RM, Demetrovics Z, Curran V, Bersani G, Singer LT.

Curr Drug Abuse Rev. 2013;6(4):255-6. No abstract available.

PMID:
25311094
18.

"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.

Corazza O, Valeriani G, Bersani FS, Corkery J, Martinotti G, Bersani G, Schifano F.

J Psychoactive Drugs. 2014 Oct-Dec;46(4):287-94. doi: 10.1080/02791072.2014.944291.

PMID:
25188698
19.

Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study.

Quartini A, Anastasia A, Bersani FS, Melcore C, Albano G, Colletti C, Valeriani G, Bersani G.

Riv Psichiatr. 2014 Jul-Aug;49(4):187-91. doi: 10.1708/1600.17460.

PMID:
25174696
20.

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.

Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F.

Biomed Res Int. 2014;2014:734749. doi: 10.1155/2014/734749. Epub 2014 Jul 3. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk